Printer Friendly

SUMMIT TECHNOLOGY GRANTED LICENSE TO IBM PATENT

 SUMMIT TECHNOLOGY GRANTED LICENSE TO IBM PATENT
 WALTHAM, Mass., March 2 /PRNewswire/ -- Summit Technology, Inc.


(NASDAQ: BEAM) announced today that IBM has granted Summit a license to IBM's patent no. 4,784,135 which covers basic methods of excimer laser tissue ablation. Under the license agreement, Summit will pay IBM 2 percent of the net sales price on ophthalmic excimer laser systems sold for use in the United States, Canada, Japan, Brazil, Australia and Spain.
 These patent rights are a significant addition to Summit's intellectual property portfolio and further secure Summit's position as the leader in the ophthalmic refractive laser industry.
 Summit Technology, Inc. has established the leadership position in designing, manufacturing and marketing ophthalmic refractive laser systems. A major focus of the company's business is in ophthalmology where applications have been developed for the treatment of common vision disorders such as nearsightedness, farsightedness, astigmatism, glaucoma, and certain corneal irregularities due to disease or injury. There are believed to be approximately 140 million people in the United States with refractive disorders. To date, over 10,000 patients have been treated worldwide by ophthalmologists using Summit's laser systems.
 -0- 3/2/92
 /CONTACT: Paula Rainville of Summit Technology, 617-890-1234/
 (BEAM) CO: Summit Technology ST: Massachusetts IN: MTC SU:


DH-TM -- NE003 -- 3750 03/02/92 08:33 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 2, 1992
Words:216
Previous Article:HILTON TO ENTER RIVERBOAT GAMING
Next Article:LIPPINCOTT CELEBRATES 200TH BIRTHDAY
Topics:


Related Articles
VISX AND SUMMIT REACH PATENT ACCORD
SPECTRUM SIGNS LICENSING AGREEMENT WITH IBM; SPECTRUM'S AXCELL CELLULAR DATA INTERFACE TECHNOLOGY EARNS IBM THINKPAD PROVEN EMBLEM
PILLAR POINT PARTNERS RESPONDS TO LAWSUIT
Casino Data Systems and International Game Technology Announce Mutual Agreement
ActaMed Announces Technology Licensing Deal With IBM
Pillar Point Partners and LaserSight Incorporated Settle Patent Litigation
Hybrid Networks Inc. Awarded Two New Cable and Wireless Modem System Patents.
IBM Slaps SCO with Countersuit.
Remediation and Technology Agreement Executed with BioGenesis.
Level 3 and IBM Announce Patent Cross-License.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters